FDA Approved: YARGESA — Original Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved Edenbridge Pharmaceuticals' original ANDA for YARGESA, a generic version of miglustat. Miglustat is the active ingredient and is indicated for Niem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• Yargesa (miglustat)

Snippet

ORIG AP for YARGESA (MIGLUSTAT)